Market Research Life Sciences Market Research Medical Devices Market Research Cardiac Rhythm Management Market Research

Active Implantable Medical Devices Market by Product (Cochlear Implants, Haemodynamic Support, Implantable Cardiac Pacemakers), Implant Type (Complete implantable, Partial implantable), End-User - Global Forecast 2024-2030

Best Price Guarantee Length Publisher Published Date SKU
from $4,749 183 Pages 360iResearch January, 2024 IRE18417877
Best Price Guarantee
Price from $4,749
Length 183 Pages
Publisher 360iResearch
Published Date January, 2024
SKU IRE18417877

Active Implantable Medical Devices Market by Product (Cochlear Implants, Haemodynamic Support, Implantable Cardiac Pacemakers), Implant Type (Complete implantable, Partial implantable), End-User - Global Forecast 2024-2030


The Active Implantable Medical Devices Market size was estimated at USD 2.65 billion in 2023 and expected to reach USD 2.91 billion in 2024, at a CAGR 9.92% to reach USD 5.14 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Active Implantable Medical Devices Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Active Implantable Medical Devices Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Active Implantable Medical Devices Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Abbott Laboratories, Aleva Neurotherapeutics, Allergan Inc. by AbbVie Inc., BIOTRONIK SE & Co. KG, Boston Scientific Corporation, Cochlear Ltd., CONMED Corporation, Definitive Healthcare, LLC, Demant A/S, Dentsply Sirona Inc., Globus Medical, Inc., GMED, Integra Lifesciences Holdings Corporation, Invibio Ltd., Johnson & Johnson Services, Inc., LivaNova PLC, Medtronic PLC, Microport Scientific Corporation, NuVasive, Inc., Smith & Nephew PLC, Sonova Holding AG, Straumann AG, Stryker Corporation, TÜV Rheinland AG, Zhejiang Nuoerkang Neuroelectronic Technology Co., Ltd., and Zimmer Biomet.

Market Segmentation & Coverage

This research report categorizes the Active Implantable Medical Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product

Cochlear Implants
  • Haemodynamic Support
  • Implantable Cardiac Pacemakers
  • Implantable Defibrillators
  • Implantable Glucose Monitors
  • Implantable Infusion Pumps & Accessories
  • Implantable Monitoring Devices
  • Implantable Neuro Stimulator Systems
  • Ventricular Assist Devices
  • Implant Type

    Complete implantable
  • Partial implantable
  • End-User

    Ambulatory Centers
  • Cardiac Centers
  • Dental Clinics
  • Hospitals
  • Region

    Americas

    Argentina
  • Brazil
  • Canada
  • Mexico
  • United States

    California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas
  • Asia-Pacific

    Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam
  • Europe, Middle East & Africa

    Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom
    The report offers valuable insights on the following aspects:

    1. Market Penetration: It presents comprehensive information on the market provided by key players.
    2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
    3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
    4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
    5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
    The report addresses key questions such as:

    1. What is the market size and forecast of the Active Implantable Medical Devices Market?
    2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Active Implantable Medical Devices Market?
    3. What are the technology trends and regulatory frameworks in the Active Implantable Medical Devices Market?
    4. What is the market share of the leading vendors in the Active Implantable Medical Devices Market?
    5. Which modes and strategic moves are suitable for entering the Active Implantable Medical Devices Market?


    Note: PDF & Excel + Online Access - 1 Year


    • 1. Preface
    1.1. Objectives of the Study
    1.2. Market Segmentation & Coverage
    1.3. Years Considered for the Study
    1.4. Currency & Pricing
    1.5. Language
    1.6. Limitations
    1.7. Assumptions
    1.8. Stakeholders
    2. Research Methodology
    2.1. Define: Research Objective
    2.2. Determine: Research Design
    2.3. Prepare: Research Instrument
    2.4. Collect: Data Source
    2.5. Analyze: Data Interpretation
    2.6. Formulate: Data Verification
    2.7. Publish: Research Report
    2.8. Repeat: Report Update
    3. Executive Summary
    4. Market Overview
    4.1. Introduction
    4.2. Active Implantable Medical Devices Market, by Region
    5. Market Insights
    5.1. Market Dynamics
    5.1.1. Drivers
    5.1.1.1. Rising prevalence of cardiovascular diseases
    5.1.1.2. Growing number of patients with neurological disorders
    5.1.1.3. Increase in awareness and adoption of neurostimulator devices
    5.1.2. Restraints
    5.1.2.1. Associated adverse health impacts of implantable medical devices
    5.1.3. Opportunities
    5.1.3.1. Integration of computing and communication capabilities in next generation IMDs
    5.1.3.2. Surging R&D investment in field of advanced medical devices
    5.1.4. Challenges
    5.1.4.1. Concern regarding high cost and stringent regulations for approval
    5.2. Market Segmentation Analysis
    5.3. Market Trend Analysis
    5.4. Cumulative Impact of High Inflation
    5.5. Porter’s Five Forces Analysis
    5.5.1. Threat of New Entrants
    5.5.2. Threat of Substitutes
    5.5.3. Bargaining Power of Customers
    5.5.4. Bargaining Power of Suppliers
    5.5.5. Industry Rivalry
    5.6. Value Chain & Critical Path Analysis
    5.7. Regulatory Framework
    6. Active Implantable Medical Devices Market, by Product
    6.1. Introduction
    6.2. Cochlear Implants
    6.3. Haemodynamic Support
    6.4. Implantable Cardiac Pacemakers
    6.5. Implantable Defibrillators
    6.6. Implantable Glucose Monitors
    6.7. Implantable Infusion Pumps & Accessories
    6.8. Implantable Monitoring Devices
    6.9. Implantable Neuro Stimulator Systems
    6.10. Ventricular Assist Devices
    7. Active Implantable Medical Devices Market, by Implant Type
    7.1. Introduction
    7.2. Complete implantable
    7.3. Partial implantable
    8. Active Implantable Medical Devices Market, by End-User
    8.1. Introduction
    8.2. Ambulatory Centers
    8.3. Cardiac Centers
    8.4. Dental Clinics
    8.5. Hospitals
    9. Americas Active Implantable Medical Devices Market
    9.1. Introduction
    9.2. Argentina
    9.3. Brazil
    9.4. Canada
    9.5. Mexico
    9.6. United States
    10. Asia-Pacific Active Implantable Medical Devices Market
    10.1. Introduction
    10.2. Australia
    10.3. China
    10.4. India
    10.5. Indonesia
    10.6. Japan
    10.7. Malaysia
    10.8. Philippines
    10.9. Singapore
    10.10. South Korea
    10.11. Taiwan
    10.12. Thailand
    10.13. Vietnam
    11. Europe, Middle East & Africa Active Implantable Medical Devices Market
    11.1. Introduction
    11.2. Denmark
    11.3. Egypt
    11.4. Finland
    11.5. France
    11.6. Germany
    11.7. Israel
    11.8. Italy
    11.9. Netherlands
    11.10. Nigeria
    11.11. Norway
    11.12. Poland
    11.13. Qatar
    11.14. Russia
    11.15. Saudi Arabia
    11.16. South Africa
    11.17. Spain
    11.18. Sweden
    11.19. Switzerland
    11.20. Turkey
    11.21. United Arab Emirates
    11.22. United Kingdom
    12. Competitive Landscape
    12.1. FPNV Positioning Matrix
    12.2. Market Share Analysis, By Key Player
    12.3. Competitive Scenario Analysis, By Key Player
    13. Competitive Portfolio
    13.1. Key Company Profiles
    13.1.1. 3M Company
    13.1.2. Abbott Laboratories
    13.1.3. Aleva Neurotherapeutics
    13.1.4. Allergan Inc. by AbbVie Inc.
    13.1.5. BIOTRONIK SE & Co. KG
    13.1.6. Boston Scientific Corporation
    13.1.7. Cochlear Ltd.
    13.1.8. CONMED Corporation
    13.1.9. Definitive Healthcare, LLC
    13.1.10. Demant A/S
    13.1.11. Dentsply Sirona Inc.
    13.1.12. Globus Medical, Inc.
    13.1.13. GMED
    13.1.14. Integra Lifesciences Holdings Corporation
    13.1.15. Invibio Ltd.
    13.1.16. Johnson & Johnson Services, Inc.
    13.1.17. LivaNova PLC
    13.1.18. Medtronic PLC
    13.1.19. Microport Scientific Corporation
    13.1.20. NuVasive, Inc.
    13.1.21. Smith & Nephew PLC
    13.1.22. Sonova Holding AG
    13.1.23. Straumann AG
    13.1.24. Stryker Corporation
    13.1.25. TÜV Rheinland AG
    13.1.26. Zhejiang Nuoerkang Neuroelectronic Technology Co., Ltd.
    13.1.27. Zimmer Biomet
    13.2. Key Product Portfolio
    14. Appendix
    14.1. Discussion Guide
    14.2. License & Pricing
    FIGURE 1. ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET RESEARCH PROCESS
    FIGURE 2. ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, 2023 VS 2030
    FIGURE 3. ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
    FIGURE 4. ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
    FIGURE 5. ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 6. ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET DYNAMICS
    FIGURE 7. ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
    FIGURE 8. ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 9. ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2023 VS 2030 (%)
    FIGURE 10. ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 11. ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
    FIGURE 12. ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 13. AMERICAS ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    FIGURE 14. AMERICAS ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 15. UNITED STATES ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
    FIGURE 16. UNITED STATES ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 17. ASIA-PACIFIC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    FIGURE 18. ASIA-PACIFIC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 21. ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET, FPNV POSITIONING MATRIX, 2023
    FIGURE 22. ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SHARE, BY KEY PLAYER, 2023

    $4,749
    $5,749
    $6,749
    $8,749

    Research Assistance

    US: 800.298.5699
    Int'l: +1.240.747.3093
    Live help
    Download our eBook: How to Succeed Using Market Research

    Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

    Download eBook

    Other tasks

    Cookie Settings